NANOG and melanoma: Kim and coworkers reported that Nanog triggers the upregulation of the tubule-associated protein 1 light chain 3 beta (LC3), which, in turn, activates the EGFR/Akt signaling, thus rendering melanoma CSCs resistant to T cell recruitment and cytotoxicity [146].